GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury

Biochemical and Biophysical Research Communications

Volumn 411, Issue 2, 2011, Pages 271-275

  Zhou, Xiaogang ^a   Zhou, Jian ^a   Li, Xilei ^a   Guo, Chang'an ^a   Fang, Taolin ^a   Chen, Zhengrong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Autophagy; GSK 3 inhibitor; Ischemic brain injury; Neuroinflammation

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BECLIN 1; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN CORTEX; BRAIN ISCHEMIA; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; INFLAMMATION; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTOPHAGY; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL CORTEX; ENCEPHALITIS; GLYCOGEN SYNTHASE KINASE 3; MALE; MICROGLIA; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 79960840961     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.117     Document Type: Article

References (29)

1. Elkind M.S. Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am. J. Med. 2009, 122:S7-S13.
2. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4:399-415.
3. Stetler R.A., Cao G., Gao Y., Zhang F., Wang S., Weng Z., Vosler P., Zhang L., Signore A., Graham S.H., Chen J. Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J. Neurosci. 2008, 28:13038-13055.
4. Bilsland J., Harper S. Caspases and neuroprotection. Curr. Opin. Investig. Drugs 2002, 3:1745-1752.
5. Fradejas N., Del Carmen Serrano-Perez M., Tranque P., Calvo S. Selenoprotein S expression in reactive astrocytes following brain injury. Glia 2011, 59:959-972.
6. Yilmaz G., Granger D.N. Cell adhesion molecules and ischemic stroke. Neurol. Res. 2008, 30:783-793.
7. Collino M., Thiemermann C., Mastrocola R., Gallicchio M., Benetti E., Miglio G., Castiglia S., Danni O., Murch O., Dianzani C., Aragno M., Fantozzi R. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 2008, 30:299-307.
8. Liang M.H., Chuang D.M. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J. Biol. Chem. 2007, 282:3904-3917.
9. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
10. Brunk U.T., Neuzil J., Eaton J.W. Lysosomal involvement in apoptosis. Redox Rep. 2001, 6:91-97.
11. Qin A.P., Liu C.F., Qin Y.Y., Hong L.Z., Xu M., Yang L., Liu J., Qin Z.H., Zhang H.L. Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy 2010, 6:738-753.
12. Dreux M., Chisari F.V. Viruses and the autophagy machinery. Cell Cycle 2010, 9:1295-1307.
13. Virgin H.W., Levine B. Autophagy genes in immunity. Nat. Immunol. 2009, 10:461-470.
14. Spencer B., Potkar R., Trejo M., Rockenstein E., Patrick C., Gindi R., Adame A., Wyss-Coray T., Masliah E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 2009, 29:13578-13588.
15. Shrivastava S., Raychoudhuri A., Steele R., Ray R., Ray R.B. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology 2011, 53:406-414.
16. Wen Y.D., Sheng R., Zhang L.S., Han R., Zhang X., Zhang X.D., Han F., Fukunaga K., Qin Z.H. Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy 2008, 4:762-769.
17. Fujishima Y., Nishiumi S., Masuda A., Inoue J., Nguyen N.M., Irino Y., Komatsu M., Tanaka K., Kutsumi H., Azuma T., Yoshida M. Autophagy in the intestinal epithelium reduces endotoxin-induced inflammatory responses by inhibiting NF-kappaB activation. Arch. Biochem. Biophys. 2011, 506:223-235.
18. Lee H.M., Shin D.M., Yuk J.M., Shi G., Choi D.K., Lee S.H., Huang S.M., Kim J.M., Kim C.D., Lee J.H., Jo E.K. Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62/SQSTM1. J. Immunol. 2011, 186:1248-1258.
19. Shi G.D., OuYang Y.P., Shi J.G., Liu Y., Yuan W., Jia L.S. PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway. Biochem. Biophys. Res. Commun. 2011, 404:941-945.
20. Vairano M., Dello Russo C., Pozzoli G., Tringali G., Preziosi P., Navarra P. A functional link between heme oxygenase and cyclo-oxygenase activities in cortical rat astrocytes. Biochem. Pharmacol. 2001, 61:437-441.
21. Fujita N., Itoh T., Omori H., Fukuda M., Noda T., Yoshimori T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 2008, 19:2092-2100.
22. Saitoh T., Fujita N., Jang M.H., Uematsu S., Yang B.G., Satoh T., Omori H., Noda T., Yamamoto N., Komatsu M., Tanaka K., Kawai T., Tsujimura T., Takeuchi O., Yoshimori T., Akira S. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-268.
23. Tu X.K., Yang W.Z., Wang C.H., Shi S.S., Zhang Y.L., Chen C.M., Yang Y.K., Jin C.D., Wen S. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats. Inflammation 2010, 33:344-352.
24. Baskaya M.K., Hu Y., Donaldson D., Maley M., Rao A.M., Prasad M.R., Dempsey R.J. Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia. J. Neurosurg. 1996, 85:112-116.
25. Li H., Li Q., Du X., Sun Y., Wang X., Kroemer G., Blomgren K., Zhu C. Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J. Cereb. Blood Flow Metab. 2011.
26. Wang M.J., Huang H.Y., Chen W.F., Chang H.F., Kuo J.S. Glycogen synthase kinase-3beta inactivation inhibits tumor necrosis factor-alpha production in microglia by modulating nuclear factor kappaB and MLK3/JNK signaling cascades. J. Neuroinflam. 2010, 7:99.
27. Huang W.C., Lin Y.S., Wang C.Y., Tsai C.C., Tseng H.C., Chen C.L., Lu P.J., Chen P.S., Qian L., Hong J.S., Lin C.F. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 2009, 128:e275-e286.
28. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
29. Yu L., Wan F., Dutta S., Welsh S., Liu Z., Freundt E., Baehrecke E.H., Lenardo M. Autophagic programmed cell death by selective catalase degradation. Proc. Natl. Acad. Sci. USA 2006, 103:4952-4957.